IPO Dekho .in

Sudeep Pharma IPO Subscription Status

Sudeep Pharma IPO subscription started on 21 November, 2025 and will close on 25 November, 2025. The retail quota is 35%, QIB is 50% and NII is 15%. Sudeep Pharma IPO got a lot of interest, raising around ₹1,50,92,750 shares (aggregating up to ₹895.00 Cr) Crores, with subscriptions 93.72 times overall, including 213.08 times by institutional investors, 116.72 times by non-institutional investors, and 15.65 times by retail investors. Shares are priced between ₹₹563 to ₹593 per share each and will be listed on the BSE and NSE.
  Check Live IPO  Subscription List  👈
List Today
Last Updated - November 25, 2025 11:55 pm

Sudeep Pharma IPO Subscription - Day 3

QIB - Qualified Institutional Buyers: 213.08x
NII - Non-Institutional Investors: 116.72x
SNII - Small Non-Institutional Investors: 80.33x
BNII - Big Non-Institutional Investors: 134.91x
RII - Retail Individual Investor: 15.65x
Total: 93.72x 👈

Sudeep Pharma IPO Investor Categories

  • Qualified Institutional Buyers: QIB
  • Non-Institutional Investors: NII
  • Small Non-Institutional Investors: SNII- Bid below ₹10L
  • Big Non-Institutional Investors: BNII- Bid above ₹10L
  • Retail Individual Investor: RII
  • Employees Quota: EMP

Sudeep Pharma IPO Dates

IPO Activity Date
Open Date: 21 November, 2025
Close Date: 25 November, 2025
Allotment Date: 26 November, 2025
Refund Date: 27 November, 2025
Shares Credit Date: 27 November, 2025
Listing Date: 28 November, 2025

Sudeep Pharma IPO Subscription Status FAQs

Q.When Sudeep Pharma IPO Subscription will start?

Ans.The IPO subscription starts on 21 November, 2025 for Investors.


Q.What is the Sudeep Pharma IPO Subscription last date?

Ans.Sudeep Pharma IPO subscription last date is 25 November, 2025 for Investors.


Q.What is the Sudeep Pharma IPO Allotment Date?

Ans.Sudeep Pharma IPO allotment date is 26 November, 2025.


Q.What is the Sudeep Pharma IPO Listing Date?

Ans.Sudeep Pharma IPO listing date is 28 November, 2025. The IPO is to list on BSE and NSE.